Clinical effectiveness of group cognitive-behavioural therapy for depressed older people in primary care. A randomised controlled trial

被引:6
|
作者
Garcia-Pena, Carmen [1 ]
Vazquez-Estupinan, Felipe [2 ]
Avalos-Perez, Fabian [3 ]
Robles Jimenez, Leslie Viridiana [1 ]
Sanchez-Garcia, Sergio [1 ]
Juarez-Cedillo, Teresa [1 ]
机构
[1] IMSS, Unidad Invest Epidemiol & Serv Salud, Area Envejecimiento, CMN SXXI, Mexico City, DF, Mexico
[2] IMSS, CMN SXXI, Hosp Especialidades, Serv Psiquiatria, Mexico City, DF, Mexico
[3] IMSS, Unidad Med Familiar 10, Mexico City, DF, Mexico
关键词
Elderly; depression; cognitive therapy; LATE-LIFE; HEALTH; VALIDATION; SYMPTOMS; VERSION; ADULTS; SF-36; PHQ-9;
D O I
10.17711/SM.0185-3325.2015.004
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Depression is associated with an increased use of medical resources and reduced quality of life, cognitive functions, functionality and general health. The treatment of depression is limited by the scarcity of mental health professionals, as reflected in the mental health atlas of the World Health Organization. Method A randomised controlled trial that was not blinded was conducted. Family doctors referred patients older than 60 years who were suspected to have depression to the screening module. The PHQ-9 questionnaire, the Six-Item Screener, and previous diagnosis for psychiatric disorders were collected. Major depression was excluded. Those with a score from two to six on the PHQ-9 and with no comorbidities were referred to the Baseline Phase. A simple random process without blocking was applied. Groups of 7-10 participants engaged in weekly sessions over the course of three months. The control group was referred to their family physician. Reduction in depression score of the PHQ-9 was the main outcome. Results and discussion There were 40 patients in the control group (CG) and 41 in the intervention group (IG). 84% were women, 41% married and 41% reported at least primary education. The mean age for the GC was 69.7 years vs. 71.3 in the GI. The baseline mean MMSE score was 23.7 in the GC and 24.1 in the IG. No significant baseline differences between groups were reported. In the IG, 56% of the participants (n=23) displayed a decrease that was greater than or equal to 5 points on the PHQ-9 compared with 30% (n=12) in the control group. The CT group evidenced a marginal improvement.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 50 条
  • [41] Pilot feasibility randomised controlled trial of cognitive-behavioural therapy for functional cognitive disorder after concussion
    Rioux, Mathilde
    Mamman, Rinni
    Byworth, Miles T.
    Panenka, William J.
    Howard, Andrew K.
    Perez, David L.
    Schmidt, Julia
    Courchesne, Caitlin
    LeMoult, Joelle
    Heran, Manraj K. S.
    Silverberg, Noah D.
    BMJ NEUROLOGY OPEN, 2024, 6 (02)
  • [42] Effectiveness of a multifactorial intervention for dizziness in older people in primary care: A cluster randomised controlled trial
    Stam, Hanneke
    van der Wouden, Johannes C.
    Hugtenburg, Jacqueline G.
    Twisk, Jos W. R.
    van der Horst, Henriette E.
    Maarsingh, Otto R.
    PLOS ONE, 2018, 13 (10):
  • [43] Cognitive-behavioural intervention for self-harm: randomised controlled trial
    Slee, Nadja
    Garnefski, Nadia
    van der Leeden, Rien
    Arensman, Ella
    Spinhoven, Philip
    BRITISH JOURNAL OF PSYCHIATRY, 2008, 192 (03) : 202 - 211
  • [44] Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder: randomised controlled fMRI trial
    Gingnell, Malin
    Frick, Andreas
    Engman, Jonas
    Alaie, Iman
    Bjorkstrand, Johannes
    Faria, Vanda
    Carlbring, Per
    Andersson, Gerhard
    Reis, Margareta
    Larsson, Elna-Marie
    Wahlstedt, Kurt
    Fredrikson, Mats
    Furmark, Tomas
    BRITISH JOURNAL OF PSYCHIATRY, 2016, 209 (03) : 229 - 235
  • [45] Group-based cognitive-behavioural anger management for people with mild to moderate intellectual disabilities: cluster randomised controlled trial
    Willner, Paul
    Rose, John
    Jahoda, Andrew
    Kroese, Biza Stenfert
    Felce, David
    Cohen, David
    MacMahnon, Pamela
    Stimpson, Aimee
    Rose, Nicola
    Gillespie, David
    Shead, Jennifer
    Lammie, Claire
    Woodgate, Christopher
    Townson, Julia
    Nuttall, Jacqueline
    Hood, Kerenza
    BRITISH JOURNAL OF PSYCHIATRY, 2013, 203 (04) : 288 - 296
  • [46] Internet-based cognitive-behavioural therapy for severe health anxiety: randomised controlled trial
    Hedman, Erik
    Andersson, Gerhard
    Andersson, Erik
    Ljotsson, Brjann
    Ruck, Christian
    Asmundson, Gordon J. G.
    Lindefors, Nils
    BRITISH JOURNAL OF PSYCHIATRY, 2011, 198 (03) : 230 - 236
  • [47] Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes
    Lewis, S
    Tarrier, N
    Haddock, G
    Bentall, R
    Kinderman, P
    Kingdon, D
    Siddle, R
    Drake, R
    Everitt, J
    Leadley, K
    Benn, A
    Grazebrook, K
    Haley, C
    Akhtar, S
    Davies, L
    Palmer, S
    Faragher, B
    Dunn, G
    BRITISH JOURNAL OF PSYCHIATRY, 2002, 181 : S91 - S97
  • [48] Effectiveness of transdiagnostic group cognitive-behavioural therapy for anxiety disorders in a naturalistic clinical setting
    Jiang, Michelle Y. W.
    Kandris, Evelyn
    El-Masry, Yasmeen
    Drobny, Juliette
    St. Clare, Tamsen
    Chen, Jessamine T. H.
    CLINICAL PSYCHOLOGIST, 2021, 25 (01) : 69 - 77
  • [49] The effect of telephone-based cognitive-behavioural therapy on parenting stress: A randomised controlled trial
    Ngai, Fei Wan
    Wong, Paul Wai-Ching
    Chung, Ma Fai
    Leung, Kwok Yin
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2016, 86 : 34 - 38
  • [50] Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial
    Kennedy, T. M.
    Chalder, T
    McCrone, P.
    Darnley, S.
    Knapp, M.
    Jones, R. H.
    Wessely, S.
    HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (19) : 1 - +